# Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT

> **NCT01282515** · PHASE2,PHASE3 · COMPLETED · sponsor: **Oslo University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Genital Lichen Planus

## Interventions

- **DRUG:** clobetasol propionate 0,05% ointment
- **DRUG:** hexaminolevulinate

## Key facts

- **NCT ID:** NCT01282515
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01282515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01282515, "Treatment of Female Genital Erosive Lichen Planus(GELP) With Hexaminolevulinate PDT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01282515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*